StockData
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. (CTKB) stock

CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.70+0.07 (+1.24%)

Close on Nov 17, 2026Market cap $740.91MP/E –Yield –

Cytek Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cytek Biosciences's price to book ratio was 2.3× on Nov 11, 2026, against 1.9× a year earlier. Over the last 5 years it ranged from 0.9× to 5.4×, with a median of 2.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.3×+0.6
2025Dec 31, 20251.7×−0.5
2024Dec 31, 20242.2×−0.8
2023Dec 29, 20233.0×−0.3
2022Dec 30, 20223.3×−2.1
2021Dec 31, 20215.4×–

More Cytek Biosciences figures

See a number that looks wrong?